RETRACTED: Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation-Reference-Cited by-同舟云学术

RETRACTED: Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation

Published:2014-01 Issue: Volume:51 Page:26-33
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Derosa Giuseppe,Cicero Arrigo F.G.,Carbone Anna,Querci Fabrizio,Fogari Elena,D’Angelo Angela,Maffioli Pamela

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference51 articles.

1. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme;Agata;Hypertens. Res.,2006

2. Fixed-dose combinations improve medication compliance: a meta-analysis;Bangalore;Am. J. Med.,2007

3. Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice;Bindom;Diabetes,2010

4. Chemerin is a novel adipokine associated with obesity and metabolic syndrome;Bozaoglu;Endocrinology,2007

5. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure;Chobanian;Hypertension,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retraction notice to “Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin” [European Journal of Pharmaceutical Sciences 51C (2013) 26–33];European Journal of Pharmaceutical Sciences;2018-10

2. Management of Hypertension Using Olmesartan Alone or in Combination;Cardiology and Therapy;2017-03-03

3. Formulations of Amlodipine: A Review;Journal of Pharmaceutics;2016-10-16

4. Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure;Disease Markers;2016

5. Retraction notice to “Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies”;Journal of the American Society of Hypertension;2015-10